Position in RNXT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,173
+$6,232 QoQ
Shares Held
7,102
+533.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. RNXT ranks #435 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RNXT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,173 | 7,102 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $941 | 1,121 | Shares | Defined | 2026-05-27 | |
| 2023-09-30 | $234 | 176 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $397 | 176 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $613 | 176 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $770 | 328 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $864 | 428 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,223 | 1,628 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $11,286 | 3,852 | Shares | Defined | 2022-10-27 | |
| No filing history on record for this holder in this stock. | ||||||